Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
Dr. Susan Love, a revered figure in the realm of oncology, has left a legacy of patient advocacy and innovative research, driving physicians to approach patient care and cancer research with empathy, courage, and forward-thinking dynamism.
Oncology, Medical July 25th 2023
The potential removal of the DIEP flap’s unique medical billing code by CMS could pose significant barriers to this beneficial breast reconstruction option, prompting calls for its preservation to ensure continued access and patient choice. Dive in to explore the implications of this pivotal issue for breast cancer patients and the health care system.
Oncology, Surgical July 10th 2023
Cleveland Clinic Journal of Medicine
As we continue to improve the sensitivity of breast imaging, the need for surgical excision of benign proliferative lesions diagnosed on core needle biopsy remains a contentious topic, calling for careful examination of acceptable excision thresholds, patient preferences, and potential disparities in care.
Dana-Farber Cancer Institute
Explore the groundbreaking findings from the TROPiCS-02 study, revealing sacituzumab govitecan as a potential game-changer in the treatment of endocrine refractory metastatic hormone receptor-positive breast cancer.
Oncology, Medical July 3rd 2023
PracticeUpdate
A phase II trial showed a significant progression-free survival benefit when patients with HR+/HER2- metastatic breast cancer switched endocrine therapy and received ribociclib, indicating the potential of this treatment strategy for those who progress on endocrine therapy and palbociclib. Learn more about the findings and implications for clinical practice.
Oncology, Medical June 27th 2023
The imminent CMS coding changes, leading to massive pay cuts, threaten to significantly reduce the availability of DIEP flap breast reconstruction, a procedure renowned for its superior patient outcomes. The potential repercussions, such as increased health disparities and a loss of specialized surgical skills, underscore the urgent need for policy reconsideration.
Oncology, Surgical June 27th 2023